I can’t comprehend how you come up with the thought Le Maître could have bought out AHZ for $45 mill Lex . How did you come up with that assumption ? If the company was on the open market including Cardiocel / TAVR and the ADAPT IP I doubt Le Maître could even come up with the cash needed to outbid the bigger players . 45 mill is lunch money for Edwards and the likes
- Forums
- ASX - By Stock
- AVR
- Ann: First in human trial commences
Ann: First in human trial commences, page-47
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$11.90 |
Change
1.050(9.68%) |
Mkt cap ! $251.5M |
Open | High | Low | Value | Volume |
$11.00 | $11.90 | $10.85 | $504.4K | 45.27K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 500 | $11.05 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$11.90 | 99 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 400 | 12.000 |
1 | 335 | 11.900 |
1 | 1000 | 11.750 |
1 | 1000 | 11.500 |
1 | 1000 | 11.300 |
Price($) | Vol. | No. |
---|---|---|
11.980 | 120 | 2 |
12.000 | 2489 | 1 |
12.050 | 9 | 1 |
12.100 | 1220 | 1 |
12.400 | 500 | 1 |
Last trade - 16.10pm 10/09/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |